Ieq Capital LLC Boosts Stake in Colgate-Palmolive (NYSE:CL)

Ieq Capital LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CLGet Rating) by 73.8% during the 3rd quarter, Holdings Channel.com reports. The firm owned 29,141 shares of the company’s stock after buying an additional 12,371 shares during the quarter. Ieq Capital LLC’s holdings in Colgate-Palmolive were worth $2,047,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of CL. Brown Advisory Inc. grew its stake in shares of Colgate-Palmolive by 3.8% during the 2nd quarter. Brown Advisory Inc. now owns 171,321 shares of the company’s stock valued at $14,106,000 after acquiring an additional 6,275 shares during the period. Walleye Capital LLC bought a new position in shares of Colgate-Palmolive in the second quarter worth approximately $1,588,000. First National Trust Co increased its stake in shares of Colgate-Palmolive by 4.8% in the third quarter. First National Trust Co now owns 5,411 shares of the company’s stock worth $381,000 after purchasing an additional 249 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund raised its position in shares of Colgate-Palmolive by 15.1% during the 2nd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 28,628 shares of the company’s stock valued at $2,294,000 after purchasing an additional 3,750 shares during the period. Finally, Cribstone Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 6.0% during the 2nd quarter. Cribstone Capital Management LLC now owns 8,693 shares of the company’s stock valued at $697,000 after buying an additional 492 shares in the last quarter. Institutional investors own 77.63% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $75.50 on Tuesday. Colgate-Palmolive has a 52 week low of $67.84 and a 52 week high of $84.75. The firm has a market capitalization of $63.06 billion, a P/E ratio of 32.83, a price-to-earnings-growth ratio of 6.61 and a beta of 0.51. The company has a fifty day simple moving average of $77.72 and a two-hundred day simple moving average of $76.73. The company has a quick ratio of 0.71, a current ratio of 1.17 and a debt-to-equity ratio of 7.81.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its earnings results on Friday, October 28th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.74. The firm had revenue of $4.46 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Colgate-Palmolive had a net margin of 10.87% and a return on equity of 304.29%. The business’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.81 EPS. Analysts anticipate that Colgate-Palmolive will post 2.97 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 14th. Stockholders of record on Monday, January 23rd will be given a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.49%. The ex-dividend date of this dividend is Friday, January 20th. Colgate-Palmolive’s dividend payout ratio is currently 81.74%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CL. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Friday, January 13th. Barclays lifted their target price on Colgate-Palmolive from $72.00 to $76.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 1st. The Goldman Sachs Group dropped their price target on Colgate-Palmolive from $91.00 to $81.00 and set a “buy” rating for the company in a research note on Monday, October 10th. Wolfe Research began coverage on shares of Colgate-Palmolive in a research report on Monday, November 21st. They set a “market perform” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Colgate-Palmolive from $85.00 to $87.00 and gave the stock a “buy” rating in a research report on Tuesday, December 6th. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $83.58.

Colgate-Palmolive Profile

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLGet Rating).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.